Tu1753: ASSOCIATION BETWEEN GLP-1 RECEPTOR AGONIST USE AND REDUCED COLORECTAL CANCER INCIDENCE IN TYPE 2 DIABETES: A REAL-WORLD COHORT STUDY

Abstract

Peer reviewed

Abdullah Sohail, Sayed Tauseef Ahmad Jan, Adnan Malik, Muhammad M. Bhinder and Douglas G. Adler

Gastroenterology (New York, N.Y. 1943), Vol.169(1), pp.S-1475-S-1476

05/2025

DOI: 10.1016/S0016-5085(25)04282-9

View Online

Title: Subtitle: Tu1753: ASSOCIATION BETWEEN GLP-1 RECEPTOR AGONIST USE AND REDUCED COLORECTAL CANCER INCIDENCE IN TYPE 2 DIABETES: A REAL-WORLD COHORT STUDY
Creators: Abdullah Sohail
Sayed Tauseef Ahmad Jan
Adnan Malik
Muhammad M. Bhinder
Douglas G. Adler
Resource Type: Abstract
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.169(1), pp.S-1475-S-1476
DOI: 10.1016/S0016-5085(25)04282-9
ISSN: 0016-5085
Language: English
Date published: 05/2025
Academic Unit: Internal Medicine
Record Identifier: 9984847248102771

1 Record Views